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Abstract: We aimed at assessing whether a head-mounted light therapy device, enriched in blue wavelengths, suppresses melatonin
secretion and improves vigilant attention in the late evening hours. We also assessed whether using such light device is associated with
discomfort and physiological stress. Seventeen healthy young participants (eight females) participated in a counterbalanced within-
subject design during which they were exposed for 2 hr before habitual sleep time to a blue-enriched light (1500 lx) or to a lower
intensity red-light (150 lx) control condition, using a new-generation light emitting diode (LED) head-mounted device. Compared to
the red light control condition, blue-enriched light signiﬁcantly reduced melatonin secretion and reaction times during a psychomotor
vigilance task while no signiﬁcant differences were detected in discomfort and cortisol levels. These results suggest that, compared to
a control condition, blue-enriched light, delivered by a new-generation head-mounted device, elicits typical non-visual responses to
light without detectable discomfort and physiological stress. They suggest that such devices might constitute an effective alternative to
standard light boxes.
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The circadian clock reﬂects an internal-based time-keeping
system, generating rhythms with a periodicity of approxi-
mately 24 hr. The master clock of this time-keeping system
is located in the suprachiasmatic nuclei of the hypothala-
mus and is heavily implicated in the temporal modulation
of sleep and wakefulness, but also melatonin secretion,
thermoregulation, pupil size, and cognition (Cajochen, Zeit-
zer, Czeisler, & Dijk, 2000; Chellappa et al., 2011; Duffy,
Kronauer, & Czeisler, 1996; Gaggioni, Maquet, Schmidt,
Dijk, & Vandewalle, 2014; Lockley et al., 2006). Cognitive
performance has been shown to present circadian rhythmic-
ity, the amplitude and, putatively, also the phase of which
depend on the investigated cognitive domain (Schmidt,
Collette, Cajochen, & Peigneux, 2007). Clock-induced
adaptive arousal mechanisms are timed to achieve a contin-
uous period of wakefulness during daytime and promote
sleep during nighttime (Borbély, 1982; Daan, Beersma, &
Borbély, 1984; Dijk & von Schantz, 2005). Accordingly,
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circadian-driven troughs in cognitive performance are clas-
sically observed towards the end of the biological night
(Schmidt et al., 2007).
Besides its central role for vision, the eye also perceives
light to regulate numerous non-visual responses, such as
the entrainment of the clock to the 24-hr light–dark cycle.
To do so, light information is absorbed by photoreceptors
at the level of the retina and is directly transmitted to the
brain via the retinohypothalamic tract (LeGates, Fernan-
dez, & Hattar, 2014).
Because of its potent effect on the circadian system, light
therapy devices are used to phase shift circadian rhythmicity
to better adapt to night shift work or transmeridian travel
(Burgess & Emens, 2016; Crowley & Eastman, 2015).
These light therapy devices were initially designed to treat
seasonal affective disorder (SAD), for which they are the
treatment of choice (Pail et al., 2011). The antidepressant
effect of light therapy in SAD seems to rely in part on circa-
dian re-entrainment (Lewy, Leﬂer, Emens, & Bauer, 2006).
Notably, besides its phase-shifting properties, light has
also been shown to acutely affect physiology and behavior.
Thus, light not only resets the phase of melatonin rhythms,
but also leads to melatonin suppression during exposure.
Finally, light has also been shown to present alerting effects
and can enhance performance in several cognitive domains,
such as vigilant attention, working memory, executive func-
tion, or declarative word-pair learning (Cajochen et al.,
2011; Chellappa et al., 2012; Lockley et al., 2006; Vande-
walle et al., 2007; Wright & Lack, 2001). Interestingly, it
has been suggested that the antidepressant effect of light
therapy in SAD also potentially relies on its ability to sup-
press melatonin secretion at night or to increase alertness
and attention (Pail et al., 2011).
Most, if not all, non-visual responses to light in humans
are more pronounced using monochromatic blue light or
using blue-enriched polychromatic light (Brainard et al.,
2001; Chellappa et al., 2012; Lockley et al., 2006; Vande-
walle et al., 2007; Wright & Lack, 2001). This blue-shifted
sensitivity is likely due to the implication of intrinsically
photosensitive retinal ganglion cells, which express the
blue-sensitive photopigment melanopsin (Gaggioni et al.,
2014; LeGates et al., 2014). It is also probably because of
these intrinsically photosensitive retinal ganglion cells that
lower intensity blue-enriched light therapy has been
reported to be as efﬁcient as standard bright white light
exposure for treating SAD (Anderson, Glod, Dai, Cao, &
Lockley, 2009; Gordijn, ‘t Mannetje, & Meesters, 2012).
Light therapy is receiving growing interest as a potential
efﬁcient means to treat an increasing number of disorders
or disabilities, including, for instance, non-seasonal major
depression (Lam et al., 2016), depression during pregnancy
(Bais et al., 2016), post-partum depression, bipolar depres-
sion or eating disorders (Terman, 2007), as well as sleep
and circadian rhythm disorders (Geerdink, Walbeek,
Beersma, Hommes, & Gordijn, 2016; van Maanen, Meijer,
van der Heijden, & Oort, 2016), addiction (Siporin, 2014),
sleep troubles in dementia (Ooms & Ju, 2016), and Parkin-
son’s disease (Videnovic et al., 2017).
The most common light therapy devices consist of light
boxes in front of which one has to sit for a given period of
time (Pail et al., 2011). This may represent a major con-
straint such that an important challenge of light therapy is
maintaining compliance (Dawson & Campbell, 1990; Pail
et al., 2011). Other approaches have been developed,
including constant changes in ceiling light delivery
(Riemersma-van der Lek et al., 2008; Viola, James, Schlan-
gen, & Dijk, 2008) or head-mounted devices (Lovato &
Lack, 2016; Stewart et al., 1990). The latter allows for por-
table individualized light therapy and may represent an
interesting alternative that increases compliance, since one
can partly continue one’s daily activities during light
administration. The efﬁcacy of head-mounted devices
remains, however, unclear, with positive (Clark, Schocket,
Turner, & Rosenthal, 1997; Stewart et al., 1990) but also
many ambiguous (Levitt, Wesson, Joffe, Maunder, & King,
1996; Rosenthal et al., 1993; Teicher et al., 1995) treatment
outcomes for SAD. Likewise, evidence suggesting that
head-mounted light therapy devices affect melatonin secre-
tion and circadian entrainment remain scarce (Boulos et al.,
2002; Lovato & Lack, 2016; Paul et al., 2007; Wright,
Lack, & Kennaway, 2004; Wright, Lack, & Partridge,
2001). Blue-green light administration through a head-
mounted LED device (2000 lx) was shown to shift circa-
dian phase and suppress melatonin secretion to a greater
extent than a white light head-mounted LED device or a
standard white light box of the same illuminance
(Lovato & Lack, 2016; Wright et al., 2001).
First-generation head-mounted devices have been
reported to induce discomfort and to impair performance
on a psychomotor vigilance task (Paul et al., 2007, 2015).
However, newer-generation head-mounted devices are
being developed. They use blue-enriched light of lower
intensities (< 2000 lx; Lovato & Lack, 2016; Slama,
Deliens, Schmitz, Peigneux, & Leproult, 2015) than
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previous devices (> 8000 lx; Paul et al., 2007) such that
they might induce less discomfort and stress.
Here, we aimed at assessing whether a type of new-
generation head-mounted light therapy device (Luminettes),
enriched in blue wavelengths, was able to suppress melato-
nin secretion and to improve alertness and vigilant attention
in the late evening, coinciding with melatonin onset. We also
evaluated whether such a light device induces discomfort
and physiological stress, assessed via salivary cortisol levels.
Materials and methods
The study was approved by the ethics committee of the
University of Liège and performed according to the Decla-
ration of Helsinki. All participants gave written informed
consent before participation.
Seventeen healthy young volunteers participated in the
study (see Table 1 for demographics). All participants were
unmedicated and indicated good subjective sleep quality
(Pittsburgh Sleep Quality Index ≤ 5; Buysse, Reynolds,
Monk, Berman, & Kupfer, 1989) and no symptoms of major
clinical depression (Beck Depression Inventory < 15; Steer,
Ball, Ranieri, & Beck, 1997) or anxiety (Beck Anxiety Inven-
tory < 16; Steer, Ranieri, Beck, & Clark, 1993). Extreme
chronotypes (score < 21 or > 70 on the Morningness–
Eveningness Questionnaire [Horne & Ostberg, 1976]) were
excluded from the study since the latter have been suggested
to differ in the phase relationship between the circadian timing
system and sleep timing (e.g., Mongrain, Carrier, & Dumont,
2006). One week before starting the laboratory part, partici-
pants kept a ﬁxed sleep–wake cycle for 7 days to ensure sufﬁ-
cient sleep and stable circadian entrainment before starting
with the experimental protocol. Scheduled sleep–wake times
were derived from an interview with the participants, taking
into account their preferred sleep–wake habits and
professional duties. Compliance to the regimen was veriﬁed
by means of actigraphic recordings. Actimetry-derived sleep
and wake-up times did not differ between the experimental
conditions (Table 1). Participants were instructed to abstain
from alcohol and caffeine during 3 days preceding each study
entrance.
The laboratory part comprised two conditions, separated
by at least 1 week and implemented as a within-subject,
pseudo-randomized, crossover design. At each visit, partici-
pants entered the laboratory 7 hr before usual bedtime. As
depicted in Figure 1, they were kept under dim light condi-
tions (< 5 lx) for 5 hr before being exposed for 2 hr to a
bright blue-enriched light (1500 lx corneal level) or to a
red light control condition (150 lx at corneal level). Light
was delivered using an LED head-mounted portable device
that includes a patented holographic surface reﬂecting light
toward the lower retina such that sight is not hindered
(Luminettes, Lucimed, Villers-Le-Bouillet, Belgium).
Photopic light stimulation was measured with a lux
meter (Q203 Radiometer, Macam Photometrics, Living-
ston, UK). Light spectra were provided by the manufacturer
(Figure 1). Estimation of spectrally weighted irradiance for
the different retinal photoreceptors showed that all photore-
ceptor types (rods, melanopsin, and S/M/L-cones) were dif-
ferently stimulated by each light condition (Table 2)
preventing any inferences on the photoreceptors contribut-
ing to the differential impact of both light conditions.
Participants were kept under dim light (< 5 lx) for 1.5 hr
following light exposure prior to leaving the lab, entailing a
wake extension of 1.5 hr with respect to habitual sleep
time. Participants were not allowed to stand up except for
scheduled bathroom visits. Social interaction was restricted
to communications with research staff. Saliva samples were
collected at hourly intervals up to light administration and
at half-hour intervals thereafter to assay melatonin and cor-
tisol levels. The samples were analyzed by LCMS/MS
Table 1
Demographic data, questionnaire scores, and actimetry data (means and standard deviations)
Sample characteristics
N (female/male) 17 (8/9)
Age (years) 22.8 (1.8)
Educational level (years) 14.26 (1.09)
Self-reported sleep quality (PSQI) 3.58 (1.17)
Chronotype (MEQ) 50.94 (7.93)
Blue light Red light p-values
Daytime propensity to fall asleep (ESS) 7.47 (4.28) 6.47 (3.35) .167
Actimetry-derived wake-up time (hh:mm) 08:04 (38 min) 08:13 (43 min) .536
Actimetry-derived sleep time (hh:mm) 23:51 (55 min) 23:56 (53 min) .453
Note. PSQI = Pittsburgh Sleep Quality Index; MEQ = Morningness–Eveningness Questionnaire; ESS = Epworth Sleepiness Scale.
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(TQ5500, Sciex, Framingham, MA, United States) for cor-
tisol (limit of quantiﬁcation: 0.1 μg/L, analytical coefﬁcient
of variation < 8.1%) and by a direct double-antibody radio-
immunoassay kit (Buhlmann, Schönenbuch, Switzerland)
for melatonin (limit of quantiﬁcation: 0.9 pg/ml, analytical
coefﬁcient of variation < 16.7%).
Concomitant to the collection of saliva samples, subjec-
tive sleepiness was assessed by the Karolinska Sleepiness
Scale (Åkerstedt & Gillberg, 1990). Furthermore, neurobe-
havioral performance was assessed by a modiﬁed version
of the Psychomotor Vigilance Task (PVT; Dinges & Pow-
ell, 1985). The PVT was administered at 10 occasions (four
pre-, four during, and two post-light exposure). During the
5-min PVT, participants were instructed to press a response
button as fast as possible as soon as a millisecond counter
appeared on the computer screen, which was displayed at
random intervals with an interstimulus interval of 2–10 s.
Feedback was provided by displaying the reaction time
(RT) for 1 s. The dependent variables were median RTs,
the mean of the 10% of fastest and slowest RTs, respec-
tively, as well as the number of lapses (RT > 500 ms, trans-
formed by √x + √x + 1 to stabilize variances according to
Basner & Dinges, 2011).
Upon arrival, participants ﬁlled in the Epworth Sleepi-
ness Scale (Johns, 1991), which quantiﬁes self-reported
propensity to fall asleep during daytime. Finally, immedi-
ately after post-light exposure, participants had to judge the
light environment on different scales. Five questions evalu-
ated general pleasure, clarity, light color, vigilance, and
concentration on a 5-point Likert scale. Visual comfort was
assessed on a scale from 1 (highly uncomfortable) to
10 (highly comfortable).
Statistical analyses were performed with SAS 9.3 (SAS
Institute, Cary, NC, United States). We used a general lin-
ear mixed model with PROC MIXED to determine the
effects of light condition (blue vs. red), session (12 time
points for subjective sleepiness, melatonin, and cortisol
levels and 10 time points for PVT performance), and the
light condition × session interaction, with the subject effect
as random factor. We also examined the effects of pre-,
during-, and post-light exposure as a repeated effect. All
repeated measures included a ﬁrst-order autoregressive
variance–covariance matrix being speciﬁed. Contrasts were
calculated with the LSMEANS statement. Degrees of
freedom of all p-values ware based on Kenward–Roger
Figure 1. Schematic illustration of the (A) experimental design and (B) light spectra.
Table 2
Light characteristics (see also Figure 1)
Blue light Red light
Peak wavelength (nm) 460 660
Photopic illuminance (lx) 1500 150
Irradiance (μW/cm2) 466 275
Photon ﬂux (ph/cm2s) 1.3 × 1015 9.1 × 1014
Spectrally weighted irradiance:
Cyanopic (S-cone) stimulation 76.7 0
Melanopic stimulation 142.4 0.02
Rhodopic stimulation 177.8 0.18
Chloropic (M-cone) stimulation 228.5 4.9
Erythro (L-cone) stimulation 251.5 35.4
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approximation for linear mixed models. The p-values of
multiple post hoc comparisons (two-tailed) were Tukey-
adjusted. Visual comfort scales were compared between
light conditions by using the non-parametric Wilcoxon test.
For vigilance and subjective sleepiness, a ﬁnal analysis
accounted for potential baseline differences by dividing the
collected values by the mean of the four sessions during
pre-light exposure.
Results
Salivary melatonin and cortisol
Besides a main effect of time, F(11, 312) = 21.32, p < .0001,
and of light condition, F(1, 312) = 12.68, p < .0005, a signiﬁ-
cant light condition × session interaction, F(11, 312) = 2.81,
p < .005, was observed for salivary melatonin levels. As
depicted in Figure 2A, melatonin levels did not differ between
conditions before light exposure, while they were signiﬁcantly
reduced in response to blue-enriched light (p < .05 for light
condition comparisons for sessions −1 to 0.5 hr relative to
habitual bed time). Similarly, when averaging the sessions
according to their occurrence with respect to the light expo-
sure (pre-, during, and post-; Figure 2, right panel), an interac-
tion between time bin and light condition was observed,
F(2, 316) = 3.67; p < .05, with post hoc comparisons
revealing that melatonin levels differed during and post- (all
ps < .05) but not pre-light exposure (p > .05). Finally, ana-
lyses of individual melatonin secretion area under the curve
(AUC) during the 2-hr light period indicated that AUC was
lower under blue (AUC = 15.4  16.12 pg/ml) compared
to red (AUC = 25.35  12.16 pg/ml) light exposure
(T = −1.97, p = .05).
For cortisol levels, a main effect of time, F(11, 312)
= 7.02, p < .0001, was detected, while neither the main
effect of light condition, F(1, 312) = 0.04, p > .5, nor its
interaction with the factor time, F(11, 312) = .62, p > .5,
reached signiﬁcance. Likewise, the light condition × time
bin (pre-, during, post-) interaction did not reach signiﬁ-
cance, F(2, 371) = 0.66, p > .5.
Vigilant attention
Performance on the PVT was assessed by computing
median RTs, means of the 10% of fastest and slowest RTs,
respectively, as well as the number of attentional lapses
(i.e., number of events with an RT > 500 ms). A main
effect of time was observed for all dependent variables
(Figure 3), such that RTs and the number of lapses
increased with time into protocol: F(9, 302) = 9.22,
p < .0001 for fast RTs; F(9, 302) = 12.47, p < .0001 for
median RTs; F(9, 302) = 9.35, p < .0001 for slow RTs;
and F(9, 302) = 6.02, p < .005 for lapses. Furthermore, a
main effect of condition was detected with lower vigilance
levels during the red compared to the blue light condition:
F(1, 302) = 3.70, p = .0552 for lapses; F(1, 302) = 22.14,
p < .0001 for fast RTs; F(1, 302) = 5.25, p < .05 for slow
RTs; and F(1, 302) = 14.51, p < .0001 for median RTs.
A signiﬁcant interaction between light condition and time
into protocol was detected for attentional lapses,
F(9, 302) = 2.30, p < .05. When grouping the sessions
according to their occurrence with respect to the light expo-
sure (pre-, during, and post-; Figure 3, right panel), a sig-
niﬁcant interaction between time bin and light condition
was observed for lapses, F(2, 316) = 3.67, p < .05, and
median RTs, F(2, 316) = 4.54, p < .05. Performance did
not signiﬁcantly differ pre-light exposure, but was
improved both during and post- (for lapses) or only post-
(for median and fast RTs) blue-light exposure compared to
red light exposure. Finally, when normalizing performance
to the mean performance of the four sessions preceding
Figure 2. Time courses of (A) salivary melatonin and (B) cortisol levels
(means and standard errors; left panel) and averaged with respect to their
occurrence according to light exposure (right panel). The grey bar indi-
cates the timing of light exposure. The X-axis of the left panel reﬂects time
in hours, relative to habitual sleep time. Red = red light condition,
blue = blue light condition. *pcorr < .05.
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light exposure, we observed a main effect of time for all
PVT measures—F(9, 268) = 3.52, p < .004 for lapses;
F(9, 286) = 9.38, p < .0001 for slow RTs; F(9, 268) =
15.39, p < .0001 for median RTs; and F(9, 298) = 11.39,
p < .0001 for fast RTs—but no main effect of the light
condition (all ps > .05), while a signiﬁcant time × light
condition interaction was observed for median RTs,
F(9, 297) = 2.21, p < .05.
Figure 3. Time courses of different Psy-
chomotor Vigilance Task (PVT) metrics (left
panel) and averaged with respect to their
occurrence according to light exposure (right
panel). The grey bar indicates the timing of
light exposure. The X-axis reﬂects time in
hours, relative to habitual sleep time.
*pcorr < .05. Circled *pcorr < .1. Red = red
light condition; blue = blue light condition.
RT = reaction time.
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Subjective sleepiness and visual comfort
Subjective sleepiness was signiﬁcantly modulated by time,
F(11, 362) = 30.52, p < .0001, as well as by the light con-
dition, F(1, 362) = 15.14, p < .0005 (Figure 4). Sleepiness
increased over the protocol and subjects felt overall sleepier
during the red compared to the blue light condition. The
time × light condition interaction was not signiﬁcant,
F(11, 362) = 0.71, p = .72, however. Similarly, when aver-
aged into three bins according to their occurrence with
respect to the light exposure (pre-, during, and post-), it
was observed that participants felt overall sleepier during
the red light condition, but the interaction between time bin
and light condition was not signiﬁcant (p > .05). Note that
volunteers already felt slightly sleepier pre-light exposure
during the red compared to the blue light condition
(4.1  0.16 for the blue light condition, 4.6  0.17 for the
red light condition; but both scores fell into the range of
feeling rather alert according to the scale). Difference in
sleepiness level pre-light exposure occurred in spite of a
counterbalanced within-subject design and in the context of
similar sleep–wake times and subjective feelings of sleepi-
ness as assessed by the Epworth Sleepiness Scale the week
prior to lab entrance (cf. Table 1). Accounting for differ-
ences at baseline, by normalizing subjective sleepiness
according to the average values of the pre-light exposure
period, a signiﬁcant effect of time, F(11, 361) = 26.46,
p < .001, but no signiﬁcant effect of light nor any time ×
light condition interaction was detected. Finally, subjec-
tively perceived glare was higher for the blue compared to
the red light condition (Table 3) but both light conditions
had an average value between 2 (too bright) and 3 (ade-
quate). All other measures of subjective feelings with
respect to light administration, including discomfort, did
not signiﬁcantly differ between conditions (Table 3).
Discussion
In accordance with previous reports, our results show that
polychromatic blue-enriched light administered via a head-
mounted device suppresses melatonin secretion (Lovato &
Lack, 2016; Paul et al., 2007; Wright et al., 2001) and
improves vigilant attention, thereby eliciting classical non-
visual effects of light. Concomitantly, blue-enriched light
exposure did not affect cortisol or subjectively assessed dis-
comfort when compared to a low-intensity control red light
administered via the same device.
Light-induced enhancement in vigilant attention has been
classically reported in in-lab settings using different light
sources. Accordingly, we observed that RTs and number of
Figure 4. Time course of subjective sleepi-
ness scores (left panel) and averaged with
respect to their occurrence according to light
exposure (right panel). The grey bar indicates
the timing of light exposure. The X-axis
reﬂects time in hours, relative to habitual
sleep time. Red = red light condition;
blue = blue light condition. KSS = Karo-
linska Sleepiness Scale.
Table 3
Subjective perception of the two light conditions (means and standard
deviations)
Blue light Red light p-value
General pleasure 3.18  0.88 3.18  0.95 .92
Clarity 2.12  0.69 2.77  0.68 .05
Color 3  0.79 2,82  0.88 .59
Vigilance 2.35  1.17 2.94  1.08 .19
Concentration 2.94  1.14 2.58  0.79 .38
Visual comfort 4.79  2.22 5.53  1.95 .28
Note. Five-point Likert scales for: general pleasure, ranging from 1 (very pleas-
ant) to 5 (very unpleasant); clarity, ranging from 1 (much too glary) to 5 (much
too dark); light color, ranging from 1 (very convenient) to 5 (inconvenient);
vigilance, from 1 (helps me to stay awake) to 5 (makes me sleepy); and concen-
tration, from 1 (helps me to stay concentrated) to 5 (disturbs my concentra-
tion). Visual comfort was evaluated on a 10-point scale ranging from 1 (highly
comfortable) to 10 (highly uncomfortable).
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lapses of attention during the performance of a psychomo-
tor vigilant task were reduced during and/or post- the blue-
enriched condition compared to the control condition.
Importantly, a previous study reported that performance on
a visuomotor task was impaired using head-mounted light
administration, potentially because of visual discomfort
and/or sight perturbation (Paul et al., 2007). Our data sug-
gest that when such discomfort is prevented and good sight
is maintained, light exposure via head-mounted devices
around bedtime can trigger the typical non-visual improve-
ment in a measure of sustained attention using the PVT
(Chellappa et al., 2011; Lockley et al., 2006). This extends
previously reported improvements in cognitive ﬂexibility
when light was administered in the afternoon using the
same head-mounted device (Slama et al., 2015). Light
effects on performance might be potentiated when asses-
sing performance under more challenging conditions, such
as acute or partial sleep deprivation or nighttime assess-
ments, for example (Lockley et al., 2006; Vandewalle
et al., 2011). Our data reveal that vigilant attention was
higher after the blue compared to the red light condition,
suggesting that the impact of the light carried over on
behavior, even once exposure was stopped. Note that light
exposure stopped at habitual bedtime. The post-light expo-
sure thus included a small period of wake extension (up to
1.5 hr after sleep onset), which is hallmarked not only by a
higher than usual build-up of sleep pressure levels but also
by the circadian gating for sleep (Lavie, 1986; Strogatz,
Kronauer, & Czeisler, 1987), thus challenging the partici-
pant’s levels of both sleepiness and vigilance.
Previous studies have shown that the use of smartphones
or computer screens, which typically include blue-enriched
LED light screens, impacted on melatonin secretion proﬁles
when compared to smartphone and computer screens from
which blue wavelengths were blocked (Cajochen et al.,
2011; Heo et al., 2017; van der Lely et al., 2015). Interest-
ingly, the differential effect of standard versus blue-light-
blocked smartphones on melatonin was detected without
any signiﬁcant difference in cortisol levels. We did not use
LED screens in the present study but, our results, like
others (e.g. Chellappa et al., 2012; Santhi et al., 2012), re-
emphasize that blue-enriched evening light exposure can
affect the secretion of melatonin, which is a hormone regu-
lated by the circadian system to frame the circadian night
and regulate the physiological processes occurring at night.
Evening head-mounted light exposure can, however, impact
melatonin without affecting cortisol, an activating hormone
with a circadian secretion proﬁle typically associated with
alerting processes during daytime.
Note that the concomitant impact of blue-enriched light
on both vigilance performance and melatonin expression
does not imply a causal relationship between these
responses. In fact, light-induced melatonin suppression is
not necessarily linked to an increase in alertness (Rüger,
Gordijn, Beersma, de Vries, & Daan, 2005; see also Higu-
chi, Fukuda, Kozaki, Takahashi, & Miura, 2011; Rahman,
Marcu, Shapiro, Brown, & Casper, 2011). Also, a light-
impact on vigilance performance has been detected during
the daytime, hallmarked by the absence of melatonin secre-
tion (Phipps-Nelson, Redman, Dijk, & Rajaratnam, 2003;
Rüger, Gordijn, Beersma, de Vries, & Daan, 2006).
The interest in light therapy is growing, as indicated, for
instance, in a recent clinical trial showing its efﬁcacy for
non-seasonal major depressive disorders (Lam et al., 2016).
Proper light therapy use is also developed to improve sleep
quality (van Maanen et al., 2016), including in organ trans-
plant (Burkhalter et al., 2015) and cancer (Johnson et al.,
2016) patients, and to reduce social jet-lag (Geerdink et al.,
2016) or prevent drowsiness at the wheel following night
shift work (light is administered prior to and not during
driving in the latter case; Weisgerber, Nikol, & Mistlberger,
2017). These types of applications may require light admin-
istration in conditions where one cannot remain seated in
front of a light box (e.g., while keeping work duties, in
ﬂight, or in a hospital bed).
The more speciﬁc interest in head-mounted light therapy
devices (also termed light visors) increased in the 1990s as
they could lead to better compliance of the patients who
could receive treatment more easily during daily activities
(Stewart et al., 1990). Interestingly, head-mounted light
therapy has been reported to be efﬁcient in re-entraining
circadian rhythmicity of melatonin secretion in real-life
experiments consisting of six-time-zone westward travel
(Boulos et al., 2002). Likewise head-mounted light therapy
was reported to improve well-being at work in hospital
medical staff (Bragard & Coucke, 2013). Furthermore,
head-mounted devices were ﬁrst considered efﬁcient as
they led to similar reduction in depressive symptoms when
compared to standard light boxes (Stewart et al., 1990).
They were also shown to be an efﬁcient replacement for
light boxes when normal light-box treatment had to be tem-
porally interrupted (i.e., after treatment initiation) when a
patient was unable to use a light box (e.g., travel; Clark
et al., 1997). Other studies, however, failed to ﬁnd positive
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results when compared to a placebo/control condition
(Levitt et al., 1996; Rosenthal et al., 1993; Teicher et al.,
1995). Reasons for such discrepancies are unclear and may
reside in the light used as the control condition
(e.g., 400-lx white light [Rosenthal et al., 1993], which
may be too high for a control condition when considering
more recent ﬁndings on the non-visual impact of light
[Zeitzer, Dijk, Kronauer, Brown, & Czeisler, 2000]) or as
active treatment (e.g., 600-lx white light [Teicher et al.,
1995], which is lower than standard white light therapy
[Pail et al., 2011]). The present study does not resolve such
debate. However, given that the administered blue-enriched
light was successful in triggering non-visual responses, our
results encourage further assessments, especially circadian
phase shifting properties. It has to be mentioned that our
protocol did not include a control condition without any
light administration. We opted for a red light control condi-
tion to minimize expectation effects and because longer
wavelength light is generally considered to induce little
non-visual effect of light on physiology and behavior
(Brainard et al., 2001; Chellappa et al., 2011; Gaggioni
et al., 2014; Lockley et al., 2006; Thapan, Arendt, &
Skene, 2001). Red light has, however, been suggested in
some studies to affect melatonin circadian rhythmicity, cor-
tisol secretion, and alertness (Figueiro, Bierman, Plitnick, &
Rea, 2009; Figueiro & Rea, 2010; Ho Mien et al., 2014).
Future studies should consider using other control condi-
tions (e.g., dim light or normal ambient indoor light) to fur-
ther assess the impact of blue-enriched light administration
through head-mounted devices. Whether differences in
light color also contribute to the effect we report should
also be investigated.
As they deliver light from a very short distance, head-
mounted devices have been reported to generate discomfort
(Paul et al., 2007, 2015). In addition, exposure to light has
been reported to trigger glucocorticoid release through mel-
anopsin photoreception signals (Pilorz et al., 2016). Using
a head-mounted device preserving good sight during expo-
sure, our results suggest that the blue-enriched light does
not elicit different levels of discomfort compared to the
red-light control condition, whether measured by subjective
scales or physiological stress assessed via salivary cortisol.
In addition, no volunteers reported headache, eyestrain,
nausea, or agitation, the most common light therapy side-
effects, during or after light administration (Pail et al.,
2011). This low incidence of apparent adverse effects/dis-
comfort might be due to the use of lower-intensity
blue-enriched light (1500 lx) than previous head-mounted
devices (8000 lx; Paul et al., 2007). As indicated by the
standard errors of our subjective measures, there is, how-
ever, some inter-individual variability in light perception.
Some participants reported blue-enriched light as having
too much glare (n = 10; < 2 on the Likert scale) or being
uncomfortable (n = 8; < 5 on the Likert scale). Note that in
the present study, light was administered while ambient
light was dim (5 lx). This type of condition can increase
backlight effects and trigger some discomfort. It is there-
fore likely that under normal use (i.e., under higher ambient
light in the home environment), any potential discomfort
may be lower. Nevertheless, the long-term use
(e.g., exposure over a longer period) of these devices on
sight, visual comfort, and also stress and non-visual
responses should be further investigated. Also, the repeti-
tive use of such light sources will putatively trigger their
phase-resetting properties on the circadian clock, which
might not be recommended in individuals who are well
entrained to the light–dark cycle. Besides exposure duration
and frequency, time of exposure should also be considered
as determinant for the effects of light on physiology and
behavior. Here we probed the impact of a single exposure
of light administered in the evening hours. We chose this
time window because the latter coincides with the onset of
melatonin secretion, one of our main variables of interest.
It has to be mentioned, however, that both phase-resetting
and acute effects of light on physiology and behavior
depend on circadian phase. According to the phase-
response curve of light (Jewett et al., 1997), morning expo-
sure induces a phase advance, while evening exposure
leads to phase delays. In the same vein, the acute effects of
light depend on time of day (Vandewalle et al., 2011).
Thus, these data cannot be generalized to light administra-
tion over the 24-hr cycle.
To sum up, our results suggest that a new-generation
head-mounted light device may be efﬁcient to improve
alertness in conditions triggering high levels of sleepiness
(e.g., long work hours, insufﬁcient sleep) or in patient
populations suffering from high levels of sleepiness. Since
head-mounted light administration was able to suppress
melatonin, which is central to circadian rhythmicity, the
head-mounted light device might also be efﬁcient to phase
shift circadian rhythms. If one uses the head-mounted light
device solely to acutely improve alertness, this phase-
shifting effect should be considered as it may not be
desired. In contrast, the potential light-induced phase
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shifting may be important for jet-lag, shift work, or mood
disorders, as suggested with other recent head-mounted
devices (Lovato & Lack, 2016; Wright et al., 2001). This
potential phase-shifting impact must be further investigated,
however. Future in-lab and ﬁeld studies should investigate
the impact of head-mounted light delivery at different times
of day and under different sleep pressure levels (e.g., during
nighttime, under jet-lag) and reevaluate whether it improves
vigilance and/or shifts circadian phase. Finally, the device’s
efﬁciency for treating health conditions, such as mood disor-
ders, should be further investigated.
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